Nvidia, AMD jump on Big Tech AI spending plans; CPI and Nvidia earnings are the next test for AI stocks

Nvidia, AMD jump on Big Tech AI spending plans; CPI and Nvidia earnings are the next test for AI stocks

New York, Feb 8, 2026, 12:07 EST — Market closed.

AI chip shares ended last week on a sharp rebound, with Nvidia up 7.8% on Friday as the Dow logged its first close above 50,000. Advanced Micro Devices rose 8.3% and Broadcom gained 7.1%, while Amazon fell 5.6% and software names such as CrowdStrike and Palantir climbed more than 4%; the Nasdaq still slipped 1.9% for the week. Ross Mayfield, an investment strategy analyst at Baird, said he sees “real demand for AI products” beneath the noise. (Reuters)

With U.S. markets closed on Sunday, the next session will test whether Friday’s rebound in AI-linked names was a reset or another bounce in a trade that has turned jumpy. Investors are drawing a harder line between the companies selling the picks and shovels and the companies paying for the build-out.

Investors are now weighing Big Tech’s planned AI spending binge — about $600 billion for 2026 — against profit pressure and a sharper threat to software and data firms. Andrew Wells, chief investment officer at SanJac Alpha, said the AI build-out trade “got too pricey” and needed a “de-risking” phase. Nvidia CEO Jensen Huang, speaking on CNBC, called demand “sky-high” and said the spending rise looked “appropriate and sustainable.” (Reuters)

Nvidia last traded at $185.41 after Friday’s close, up 7.9% on the day. AMD ended at $208.44, up 8.2%, and Broadcom closed at $332.92, up 7.1%. Amazon finished at $210.32, down 5.6%, while Alphabet fell 2.5% and Microsoft added 1.8%.

Investors’ focus is capex — capital spending on things like data centers, chips and network gear. Amazon projected more than a 50% rise in capex this year and put the tally at about $200 billion, up from $131 billion in 2025, Reuters reported. CEO Andy Jassy told investors AWS growth looks different “on a $142 billion annualized run rate” than at smaller rivals. (Reuters)

That spending pipeline is why chipmakers rallied even as some cloud stocks took hits. The market is betting the build-out keeps orders coming, even if it squeezes margins at the companies writing the checks.

Software and data-services groups sit on the other side of the trade, where AI could automate parts of what they sell. Traders have started to punish firms that look exposed to that risk, or simply priced for perfection.

But the split also leaves AI stocks vulnerable to fast reversals. If companies pull back on spending, or if projects fail to turn into sales, the most crowded AI chip names can drop hard.

With the market shut this weekend, traders head into Monday looking for any fresh read on budgets and demand, not just AI headlines. A quiet Sunday can still turn loud once futures reopen and investors start gaming the next catalyst.

The next big macro test is the U.S. Consumer Price Index for January, due Feb. 13 at 8:30 a.m. ET. CPI is a key inflation gauge and can swing interest-rate bets, which often drive valuations for tech and other growth stocks. (Bureau of Labor Statistics)

For AI chip shares, the next hard catalyst is Nvidia’s fourth-quarter results and outlook on Feb. 25, with the company set to webcast the report at 2 p.m. PT. Investors will look for any signal on data-center demand and whether the capex wave turns into real orders. (investor.nvidia.com)

Stock Market Today

  • Summit Therapeutics Shares Appear Significantly Undervalued Amid Recent Pullback
    February 8, 2026, 1:51 PM EST. Summit Therapeutics (SMMT) stock closed at $14.99 after a recent 3.5% weekly gain but has declined 23.8% over 30 days and 25.5% over the past year. Despite these pullbacks, the company has delivered strong multi-year returns, including a 94.7% five-year gain. Using a Discounted Cash Flow (DCF) model, which estimates future cash flows discounted to present value, Summit appears undervalued by 93.3%, with an intrinsic value estimated at $224.46 per share. The firm reported a $270 million free cash flow loss over the past year but projects substantial cash flow growth by 2030. However, Summit scores only 2 out of 6 on valuation metrics, suggesting caution amid investment risks in the pharmaceutical and biotech sectors.

Latest article

Big Tech stocks brace for AI spending scrutiny after Nvidia’s jump and Amazon’s drop

Big Tech stocks brace for AI spending scrutiny after Nvidia’s jump and Amazon’s drop

8 February 2026
The Dow closed above 50,000 for the first time Friday as Nvidia surged 7.9% and Amazon dropped 5.6% on news of a $200 billion capex plan for 2026. Tech stocks remain volatile, with chipmakers rallying and software names under pressure as investors react to soaring AI infrastructure costs. The S&P 500 rose 2%, while the Russell 2000 jumped 3.5%. Alphabet, Meta, and Microsoft are also expected to boost spending sharply this year.

Popular

XRP price today: Weekend bounce holds near $1.42 as traders brace for more volatility
Previous Story

XRP price today: Weekend bounce holds near $1.42 as traders brace for more volatility

Natural gas prices head into a new week under pressure as drilling rises and forecasts turn milder
Next Story

Natural gas prices head into a new week under pressure as drilling rises and forecasts turn milder

Go toTop